![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Krka, D.d., Novo Mesto Novo Mesto Si, based in Slovenia, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Atorvastatin calcium, 315313, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-105 - Rev 01
This Chemical Type CEP, issued on January 28, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2191 associated with this CEP further emphasizes